# TruCBN™

**TruCBN™ is a proprietary formulation of cannabinoids aimed at improving sleep quality through randomized clinical trials.**

**Category:** clinical_trial_method  
**Maturity:** emerging

## How It Works

TruCBN™ involves a randomized, double-blind, placebo-controlled trial design to assess the effectiveness of various formulations of cannabinol (CBN) and melatonin on sleep quality. Participants are assigned to different groups receiving either a placebo, melatonin, or varying doses of CBN. Their sleep quality and other health metrics are evaluated through weekly surveys over a six-week period, allowing researchers to analyze the data for significant improvements in sleep and overall well-being.

## Algorithm

**Input:** Participants' demographic data, baseline health assessments, and weekly survey responses.

**Output:** Changes in sleep quality, stress, anxiety, pain, and overall well-being scores.

**Steps:**

1. 1. Recruit participants and obtain informed consent.
2. 2. Randomly assign participants to one of five groups: placebo, 4 mg melatonin, 25 mg CBN, 50 mg CBN, or 100 mg CBN.
3. 3. Instruct participants to take one softgel 1-2 hours before bedtime.
4. 4. Collect baseline health outcome assessments using validated measures.
5. 5. Administer weekly online surveys for six weeks to assess sleep quality and side effects.
6. 6. Analyze data using linear mixed-effects regression models.

**Core Operation:** `output = changes in sleep quality, stress, anxiety, pain, and overall well-being scores`

## Parameters

| Parameter | Typical Value | Effect |
|-----------|--------------|--------|
| `softgel A` | 4 mg melatonin | may improve sleep quality |
| `softgel B` | 25 mg CBN | may improve sleep quality |
| `softgel C` | 50 mg CBN | may improve sleep quality |
| `softgel D` | 100 mg CBN | may improve sleep quality |
| `placebo` | no active ingredients | serves as a control group |

## Complexity

- **Time:** O(n)
- **Space:** O(1)
- **In practice:** The complexity is primarily dependent on the number of participants and the duration of the trial.

## Implementation

```python
def truCBN_trial(participants: List[Participant]) -> Results:
    assign_groups(participants)
    for week in range(6):
        collect_data(participants)
        analyze_data(participants)
    return results
```

## Common Mistakes

- Failing to properly randomize participant assignments.
- Not collecting baseline health assessments before the trial.
- Inadequate monitoring of participant adherence to the softgel regimen.

## Use When

- Developing alternative sleep aids for consumers seeking non-prescription options.
- Conducting clinical trials for dietary supplements targeting sleep improvement.
- Exploring the effects of cannabinoids on health and wellness.

## Avoid When

- The target population does not experience sleep disturbances.
- Participants are on medications that may interact negatively with cannabinoids.
- Conducting trials that require in-person monitoring.

## Tradeoffs

**Strengths:**

- Provides evidence-based insights into the effectiveness of cannabinoid formulations.
- Utilizes a robust clinical trial design to minimize bias.
- Offers a potential alternative to prescription sleep aids.

**Weaknesses:**

- Results may vary significantly based on individual responses to cannabinoids.
- Limited generalizability if the sample size is small.
- Potential for adverse effects in certain populations.

**Compared To:**

- **vs traditional sleep medications:** TruCBN™ may offer a natural alternative with fewer side effects.

## Connects To

- clinical trial methodology
- cannabinoid research
- sleep science
- dietary supplement efficacy studies

## Evidence (Papers)

- **A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Effectiveness and Safety of Melatonin and Three Formulations of Floraworks Proprietary TruCBN for Improving Sleep** - [DOI](https://doi.org/10.3390/ph17080977)
